BASEL, Switzerland, April 19, 2004 (PRIMEZONE) -- We would like to remind you that Roche will publish its Sales Results for the 1st Quarter of 2004 prior to the opening of the Swiss Stock Exchange on Wednesday, 21st April 2004.
07.00h CET (Central European time) Release will be e-mailed and posted on the Roche IR website. Presentation slides will be posted on the Roche IR website http://ir.roche.com.
14.00h - 15.30h CET (Central European time)
Conference call will commence with presentations by senior
management followed by a 30-minutes Q&A session (live access to
the speakers).
Participants will be:
Dr. Erich Hunziker, Chief Financial Officer
William M. Burns, Head of the Pharmaceuticals Division
Heino von Prondzynski, Head of the Diagnostics Division
Analysts are invited to dial in to the conference using the
following dial-in numbers:
+41 - 91 - 610 56 00 (Europe and ROW)
+44 - 207 - 107 06 11 (UK)
+1 - 866 - 291 41 66 (USA)
Please dial into the conference call 10 - 15 minutes before the call is scheduled to start. You are also invited to download the presentation from the website. Alternatively you can follow the conference as a live audio-only webcast through the Internet site http://ir.roche.com.
A replay of the conference call will be available one hour
after the conference call, for 48 hours. Access is by dialling:
+41 - 91 - 612 43 30 (Europe and ROW)
+44 - 207 - 866 43 00 (UK)
+1 - 412 - 858 14 40 (USA)
enter conference ID 179 followed by the # sign
A replay of the webcast will be available on demand at htt://ir.roche.com.
Looking forward to your participation and best regards,
Karl Mahler
Head of Investor Relations
The Investor Update can be downloaded from the following link: http://hugin.info/100334/R/941792/131422.pdf